Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (9 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (17)
Guidance programme
(
7 selected
)
Guidance programme
Clinical guidelines (2)
Diagnostics guidance (2)
Health technology evaluations (1)
Interventional procedures guidance (1)
Medical technologies guidance (0)
NICE guidelines (2)
Technology appraisal guidance (11)
Apply filters
Showing 11 to 17 of 17
Sort by
Date
Title
Apply sorting
Last updated date between 1/5/2023 and 31/5/2023
Remove Last updated date between 1/5/2023 and 31/5/2023 filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Clinical guidelines
Remove Guidance programme: Clinical guidelines filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: NICE guidelines
Remove Guidance programme: NICE guidelines filter
Guidance programme: Health technology evaluations
Remove Guidance programme: Health technology evaluations filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy
TA886
10 May 2023
10 May 2023
Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer
TA887
10 May 2023
10 May 2023
Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment
HTE7
4 May 2023
4 May 2023
Ripretinib for treating advanced gastrointestinal stromal tumour after 3 or more treatments
TA881
3 May 2023
3 May 2023
Voclosporin with mycophenolate mofetil for treating lupus nephritis
TA882
3 May 2023
3 May 2023
Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma
TA883
3 May 2023
3 May 2023
Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal)
TA884
3 May 2023
3 May 2023
Previous page
1
Current page
2
Page
2
of
2
Results per page
10
25
50
All
Back to top